Bio Protocol's V2 launch and new 2025 DeSci roadmap are overshadowed by community frustration. Major token unlocks are fueling sell pressure and widespread accusations of manipulation, leading to bearish sentiment and calls for delisting.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.